Cargando…

New insights into structure and function of bis-phosphinic acid derivatives and implications for CFTR modulation

C407 is a compound that corrects the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein carrying the p.Phe508del (F508del) mutation. We investigated the corrector effect of c407 and its derivatives on F508del-CFTR protein. Molecular docking and dynamics simulations combined with site...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bitam, Sara, Elbahnsi, Ahmad, Creste, Geordie, Pranke, Iwona, Chevalier, Benoit, Berhal, Farouk, Hoffmann, Brice, Servel, Nathalie, Baatalah, Nesrine, Tondelier, Danielle, Hatton, Aurelie, Moquereau, Christelle, Faria Da Cunha, Mélanie, Pastor, Alexandra, Lepissier, Agathe, Hinzpeter, Alexandre, Mornon, Jean-Paul, Prestat, Guillaume, Edelman, Aleksander, Callebaut, Isabelle, Gravier-Pelletier, Christine, Sermet-Gaudelus, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994384/ https://www.ncbi.nlm.nih.gov/pubmed/33767236 http://dx.doi.org/10.1038/s41598-021-83240-x

Ejemplares similares

Author Correction: New insights into structure and function of bis-phosphinic acid derivatives and implications for CFTR modulation
por: Bitam, Sara, et al.
Publicado: (2021)

An unexpected effect of TNF-α on F508del-CFTR maturation and function
por: Bitam, Sara, et al.
Publicado: (2015)

Acting on the CFTR Membrane-Spanning Domains Interface Rescues Some Misfolded Mutants
por: Baatallah, Nesrine, et al.
Publicado: (2022)

Systemic bis-phosphinic acid derivative restores chloride transport in Cystic Fibrosis mice
por: da Cunha, Mélanie Faria, et al.
Publicado: (2022)

Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
por: Pranke, Iwona, et al.
Publicado: (2019)

Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons
por: Pranke, Iwona, et al.
Publicado: (2018)

Sweat Chloride Testing and Nasal Potential Difference (NPD) Are Primary Outcome Parameters in Treatment with Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2021)

Differential CFTR-Interactome Proximity Labeling Procedures Identify Enrichment in Multiple SLC Transporters
por: Chevalier, Benoît, et al.
Publicado: (2022)

Urinary Exosomes of Patients with Cystic Fibrosis Unravel CFTR-Related Renal Disease
por: Gauthier, Sebastien, et al.
Publicado: (2020)

Unsolved severe chronic rhinosinusitis elucidated by extensive CFTR genotyping
por: Degrugillier, Fanny, et al.
Publicado: (2019)

Functional and Pharmacological Characterization of the Rare CFTR Mutation W361R
por: Billet, Arnaud, et al.
Publicado: (2020)

Moving the Dial on Airway Inflammation in Response to Trikafta in Adolescents with Cystic Fibrosis
por: Lepissier, Agathe, et al.
Publicado: (2023)

Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis
por: Simonin, Juliette, et al.
Publicado: (2019)

Author Correction: Airway surface liquid acidification initiates host defense abnormalities in Cystic Fibrosis
por: Simonin, Juliette, et al.
Publicado: (2019)

Characterization of Non-Trivial Neighborhood Fold Constraints from Protein Sequences using Generalized Topohydrophobicity
por: Fourty, Guillaume, et al.
Publicado: (2008)

Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
por: Pranke, Iwona M., et al.
Publicado: (2017)

Digging into the 3D Structure Predictions of AlphaFold2 with Low Confidence: Disorder and Beyond
por: Bruley, Apolline, et al.
Publicado: (2022)

Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice
por: Saussereau, Emilie Lyne, et al.
Publicado: (2013)

Prediction of the general transcription factors associated with RNA polymerase II in Plasmodium falciparum: conserved features and differences relative to other eukaryotes
por: Callebaut, Isabelle, et al.
Publicado: (2005)

Elexacaftor/Tezacaftor/Ivacaftor Disrupts Respiratory Tract Development in a Murine Fetal Lung Explant Model
por: Lhuillier, Mickaël, et al.
Publicado: (2022)

A generalized analysis of hydrophobic and loop clusters within globular protein sequences
por: Eudes, Richard, et al.
Publicado: (2007)

Insights into the Role of the Discontinuous TM7 Helix of Human Ferroportin through the Prism of the Asp325 Residue
por: Le Tertre, Marlène, et al.
Publicado: (2021)

Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator–IL-6–antimicrobial–repair pathway
por: Saint-Criq, Vinciane, et al.
Publicado: (2018)

Characterization of two rat models of cystic fibrosis—KO and F508del CFTR—Generated by Crispr‐Cas9
por: Dreano, Elise, et al.
Publicado: (2019)

The CF-CIRC study: a French collaborative study to assess the accuracy of Cystic Fibrosis diagnosis in neonatal screening
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2006)

Isolation, cultivation, and application of primary respiratory epithelial cells obtained by nasal brushing, polyp samples, or lung explants
por: Golec, Anita, et al.
Publicado: (2022)

Airway Surface Liquid pH Regulation in Airway Epithelium Current Understandings and Gaps in Knowledge
por: Zajac, Miroslaw, et al.
Publicado: (2021)

Achromobacter xylosoxidans airway infection is associated with lung disease severity in children with cystic fibrosis
por: Marsac, Charlotte, et al.
Publicado: (2021)

Mucoviscidosis: fisiopatología, genética, aspectos clínicos y terapéuticos
por: Noël, S., et al.
Publicado: (2020)

Dataset of differential lipid raft and global proteomes of SILAC-labeled cystic fibrosis cells upon TNF -α stimulation
por: Chhuon, C., et al.
Publicado: (2016)

A Novel Lipidomic Strategy Reveals Plasma Phospholipid Signatures Associated with Respiratory Disease Severity in Cystic Fibrosis Patients
por: Guerrera, Ida Chiara, et al.
Publicado: (2009)

Determinants of Refusal of A/H1N1 Pandemic Vaccination in a High Risk Population: A Qualitative Approach
por: d'Alessandro, Eugenie, et al.
Publicado: (2012)

Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: patient-reported outcomes in the STRIVE randomized, controlled trial
por: Quittner, Alexandra, et al.
Publicado: (2015)

In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2007)

β‐adrenergic sweat test in children with inconclusive cystic fibrosis diagnosis: Do we need new reference ranges?
por: Zampoli, Marco, et al.
Publicado: (2022)

Ivacaftor-Mediated Potentiation of ABCB4 Missense Mutations Affecting Critical Motifs of the NBDs: Repositioning Perspectives for Hepatobiliary Diseases
por: Delaunay, Jean-Louis, et al.
Publicado: (2023)

Impact of COVID-19 on people with cystic fibrosis
por: Colombo, Carla, et al.
Publicado: (2020)

Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain
por: Odolczyk, Norbert, et al.
Publicado: (2013)

Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators
por: Fajac, Isabelle, et al.
Publicado: (2021)

Exponential amplification by redox cross-catalysis and unmasking of doubly protected molecular probes
por: Pallu, Justine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_26g5en4ebeajtbpitecjr1gque